Bioxyne Ltd (BXN) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.064x

Based on the latest financial reports, Bioxyne Ltd (BXN) has a cash flow conversion efficiency ratio of -0.064x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.29 Million ≈ $-915.87K USD) by net assets (AU$20.17 Million ≈ $14.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Bioxyne Ltd to measure how many days the company can operate on defensive assets alone.

Bioxyne Ltd - Cash Flow Conversion Efficiency Trend (2000–2025)

This chart illustrates how Bioxyne Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Bioxyne Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bioxyne Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Bokusgruppen AB
ST:BOKUS
-0.100x
After You Public Company Limited
BK:AU
0.122x
Acres Commercial Realty Corp
NYSE:ACR
-0.022x
Shanghai Huayi Group Corp Ltd B
SHG:900909
-0.074x
Carbios
PA:ALCRB
-0.090x
Taiwan Line Tek Electronic Co Ltd
TW:2462
0.027x
Microbot Medical Inc
NASDAQ:MBOT
-0.068x
Maywood Acquisition Corp. Class A Ordinary Shares
NASDAQ:MAYA
-0.002x

Annual Cash Flow Conversion Efficiency for Bioxyne Ltd (2000–2025)

The table below shows the annual cash flow conversion efficiency of Bioxyne Ltd from 2000 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Bioxyne Ltd worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$11.38 Million
≈ $8.05 Million
AU$6.28 Million
≈ $4.44 Million
0.552x +151.14%
2024-06-30 AU$3.30 Million
≈ $2.33 Million
AU$-3.56 Million
≈ $-2.52 Million
-1.079x -1331.48%
2023-06-30 AU$15.01 Million
≈ $10.62 Million
AU$-1.13 Million
≈ $-800.27K
-0.075x -105.43%
2022-06-30 AU$-364.84K
≈ $-258.15K
AU$-506.81K
≈ $-358.60K
1.389x +4955.72%
2021-06-30 AU$1.93 Million
≈ $1.37 Million
AU$53.13K
≈ $37.60K
0.027x +48.59%
2020-06-30 AU$2.61 Million
≈ $1.85 Million
AU$48.25K
≈ $34.14K
0.018x +104.18%
2019-06-30 AU$3.14 Million
≈ $2.22 Million
AU$-1.39 Million
≈ $-983.77K
-0.442x -3.07%
2018-06-30 AU$4.32 Million
≈ $3.06 Million
AU$-1.86 Million
≈ $-1.31 Million
-0.429x -318.22%
2017-06-30 AU$4.13 Million
≈ $2.92 Million
AU$-424.05K
≈ $-300.04K
-0.103x -145.65%
2016-06-30 AU$1.55 Million
≈ $1.10 Million
AU$348.85K
≈ $246.84K
0.225x +273.10%
2015-06-30 AU$1.28 Million
≈ $908.28K
AU$-166.77K
≈ $-118.00K
-0.130x -122.95%
2014-06-30 AU$1.07 Million
≈ $758.45K
AU$606.76K
≈ $429.32K
0.566x -87.72%
2013-06-30 AU$-210.73K
≈ $-149.10K
AU$-971.70K
≈ $-687.54K
4.611x +678.23%
2012-06-30 AU$5.89 Million
≈ $4.17 Million
AU$-4.70 Million
≈ $-3.32 Million
-0.797x -29.84%
2011-06-30 AU$124.34K
≈ $87.98K
AU$-76.37K
≈ $-54.04K
-0.614x -149.79%
2010-06-30 AU$123.29K
≈ $87.23K
AU$152.07K
≈ $107.60K
1.233x +110.83%
2009-06-30 AU$43.15K
≈ $30.53K
AU$-491.48K
≈ $-347.75K
-11.391x -751.42%
2008-06-30 AU$-623.12K
≈ $-440.90K
AU$-1.09 Million
≈ $-770.99K
1.749x +128.21%
2007-06-30 AU$218.65K
≈ $154.71K
AU$-1.36 Million
≈ $-958.87K
-6.198x -12.44%
2006-06-30 AU$410.58K
≈ $290.51K
AU$-2.26 Million
≈ $-1.60 Million
-5.512x +71.34%
2005-06-30 AU$186.98K
≈ $132.30K
AU$-3.60 Million
≈ $-2.54 Million
-19.232x -365.33%
2004-06-30 AU$1.18 Million
≈ $831.58K
AU$-4.86 Million
≈ $-3.44 Million
-4.133x +19.97%
2003-06-30 AU$967.78K
≈ $684.77K
AU$-5.00 Million
≈ $-3.54 Million
-5.164x -386.06%
2002-06-30 AU$4.26 Million
≈ $3.01 Million
AU$-4.52 Million
≈ $-3.20 Million
-1.063x -228.39%
2001-06-30 AU$9.02 Million
≈ $6.39 Million
AU$-2.92 Million
≈ $-2.07 Million
-0.324x -258.68%
2000-06-30 AU$12.43 Million
≈ $8.80 Million
AU$-1.12 Million
≈ $-793.44K
-0.090x --

About Bioxyne Ltd

AU:BXN Australia Packaged Foods
Market Cap
$166.41 Million
AU$235.19 Million AUD
Market Cap Rank
#18562 Global
#582 in Australia
Share Price
AU$0.11
Change (1 day)
+9.37%
52-Week Range
AU$0.03 - AU$0.11
All Time High
AU$0.12
About

Bioxyne Limited, together with its subsidiaries, manufactures and distributes therapeutic goods, and health and wellness products in Australia, the United States, the United Kingdom, Czechia, Switzerland, France, Germany, and Japan. It operates through Pharmaceutical Manufacture and Wholesale Supply of Novel Medicines, Cannabis, Psilocybin, and MDMA; Manufacture and Distribution (Wholesale, Onlin… Read more